World Library  
Flag as Inappropriate
Email this Article

Kinetic Concepts

Article Id: WHEBN0015985743
Reproduction Date:

Title: Kinetic Concepts  
Author: World Heritage Encyclopedia
Language: English
Subject: Aderis Pharmaceuticals, Qualitest, Cortex Pharmaceuticals, S. E. Massengill Company, Proteon Therapeutics
Collection:
Publisher: World Heritage Encyclopedia
Publication
Date:
 

Kinetic Concepts

Kinetic Concepts
Private company
Industry Medical devices, Medical technology
Founded San Antonio, Texas, 1976 (1976)
Headquarters San Antonio, Texas, United States
Key people
James R. Leininger (founder), Joseph F. Woody, President and CEO
Products Items related to negative pressure wound therapy and wound healing[1]
Revenue $1.6 billion Increase (2010)
$256.1 million Increase (2010)
Number of employees
5,000 (2013)
Slogan The Clinical Advantage
Website .com.kci1www

Kinetic Concepts, Inc., (KCI) is a global corporation that produces medical technology related to wounds and wound healing. KCI produced the first product developed specifically for negative pressure wound therapy. As of 2013 the company employs 5,000 people and markets its products in more than 25 countries.[2] Its headquarters is in San Antonio, Texas. Currently, KCI, LifeCell and Systagenix operate under one global medical technology brand known as Acelity.

Operations

KCI is composed of three business units: Active Healing Solutions, LifeCell and Therapeutic Support Systems, that operate in the wound care, regenerative medicine and therapeutic support systems markets.[3][4] The largest of these business units is dedicated to wound care[5] primarily negative pressure wound therapy for the treatment of traumatic wounds, pressure ulcers, chronic wounds and diabetic ulcers[6] but also assistance with surgery.[7] The therapeutic support systems developed and supplied by KCI are largely for the treatment and prevention of complications associated with patient immobility.[8] These include support surfaces for hospital beds and home patients designed to address pulmonary complications in immobile patients. KCI also develops specialty beds for use in hospitals or in long-term care facilities.[9] KCI expanded into the regenerative medicine market in 2008.[3] Through subsidiary company LifeCell Corporation, KCI develops and supplies tissue-based products. These include tissue-based treatments used in surgical procedures to repair soft-tissue.[10]

Corporate history

KCI was founded in 1976 in San Antonio, Texas, by James R. Leininger, then an emergency room physician[8] who wanted to help prevent the pulmonary complications associated with immobility. Over time, the company developed or acquired a line of therapeutic specialty beds, introducing a specialty bed for acute care patients with pulmonary complications.[11] Initially KCI's product development focused on therapeutic beds and surfaces then expanded to introduce the first commercial negative pressure wound therapy products in the mid-1990s.[7][12] KCI acquired regenerative medicine company, LifeCell, in 2008 [3] in a non-hostile transaction for US$1.7 billion.[13][14] In January 2012, LifeCell was made a sister company to KCI.


Financial information

From the founding of the company in 1976 to 1988, the revenue of KCI grew to US$153.2 million. The growth in revenue allowed KCI to go public and trade on the New York Stock Exchange (NYSE) in 1988.[15] KCI stock was traded on the NYSE until 1997, when the company went private. In February 2004, KCI became a publicly listed company for the second time and was listed on the NYSE under the ticker symbol KCI.[7][16] By the late 2000s the company's revenue was over $1 billion and reported an increase of 17 percent in 2007 to $1.61 billion.[17] Revenue for 2008 was $1.88 billion, increasing to $1.99 billion in 2009[18] and in 2010 increased to $2.02 billion.[19] On November 4, 2011, the company went private again at a price of $68.50 per share. KCI is owned by a consortium consisting of Apax Partners and controlled affiliates of the Canada Pension Plan Investment Board and Public Sector Pension Investment Board.

Product lines

  • V.A.C. systems used for negative pressure wound therapy.[20]

See also

References

  1. ^
  2. ^
  3. ^ a b c
  4. ^
  5. ^
  6. ^
  7. ^ a b c
  8. ^ a b
  9. ^
  10. ^
  11. ^
  12. ^
  13. ^
  14. ^
  15. ^
  16. ^
  17. ^
  18. ^
  19. ^
  20. ^

External links

  • Official KCI Site
  • Official LifeCell Site
This article was sourced from Creative Commons Attribution-ShareAlike License; additional terms may apply. World Heritage Encyclopedia content is assembled from numerous content providers, Open Access Publishing, and in compliance with The Fair Access to Science and Technology Research Act (FASTR), Wikimedia Foundation, Inc., Public Library of Science, The Encyclopedia of Life, Open Book Publishers (OBP), PubMed, U.S. National Library of Medicine, National Center for Biotechnology Information, U.S. National Library of Medicine, National Institutes of Health (NIH), U.S. Department of Health & Human Services, and USA.gov, which sources content from all federal, state, local, tribal, and territorial government publication portals (.gov, .mil, .edu). Funding for USA.gov and content contributors is made possible from the U.S. Congress, E-Government Act of 2002.
 
Crowd sourced content that is contributed to World Heritage Encyclopedia is peer reviewed and edited by our editorial staff to ensure quality scholarly research articles.
 
By using this site, you agree to the Terms of Use and Privacy Policy. World Heritage Encyclopedia™ is a registered trademark of the World Public Library Association, a non-profit organization.
 


Copyright © World Library Foundation. All rights reserved. eBooks from Project Gutenberg are sponsored by the World Library Foundation,
a 501c(4) Member's Support Non-Profit Organization, and is NOT affiliated with any governmental agency or department.